Zensun Sci & Tech, Ltd., a biopharmaceutical company based in Shanghai and San Diego, announced today positive results of four completed Phase 2 clinical trials including three double-blind, placebo-controlled studies conducted in China and Australia and interim results from the United States Phase 2 trial for Zensun’s innovative “first-in-class” anti-heart failure drug, Neucardin™.
To view Multimedia News Release, go to http://www.multivu.com/mnr/61677-zensun-completes-clinical-trials-of-neucardin-treatment-of-heart-failure
A pill designed to zero in on abnormal genes that drive specific cancers has produced encouraging early results in children with an uncommon but aggressive type of lymphoma, as well as in children with a rare form of neuroblastoma.
A phase 1 clinical trial of the drug crizotinib achieved remissions, with minimal side effects, for 10 of the children participating in a clinical study carried out by the multicenter Children’s Oncology Group (COG). The results were “an exciting proof-of-principle” for the targeted treatment, said the study leader, Yaël P. Mossé, M.D., a pediatric oncologist at The Children’s Hospital of Philadelphia.
“We are entering a new era of cancer therapy, in which we use knowledge of basic biology to design very specific drugs that target cancer cells with potentially less side effects on healthy tissue,” said Mossé. “In addition, as we concentrate on targets in molecular pathways, we move away from an exclusive focus on one form of cancer to customizing treatments according to biological activity. Abnormal ALK activity occurs in subtypes of neuroblastoma and subtypes of lymphoma, so identifying ALK activity in individual patients may enable us to provide the most effective care.”
To view Multimedia News Release, go to http://www.multivu.com/mnr/50776-childrens-hospital-philadelphia-lymphoma-neuroblastoma-oncology-gene-trial
Today, WebMD released In Their Own Words: Moving Beyond Migraine with Robin Roberts, a new five-part video series that sheds light on the debilitating nature of migraine and the impact it has on all aspects of a sufferer’s personal and professional life.
To learn more about treatments and the individuals featured in In Their Own Words: Moving Beyond Migraine with Robin Roberts, visit: to www.webmd.com/insidemigraines.
Moving Beyond Migraine follows the lives of Jennifer, a public school administrator who has lived with intense migraine headaches for over 20 years; Kate, a 20-year-old college student with debilitating migraines that have run in her family for generations; Melanie, whose intense migraine condition has altered the dynamics of her nine year marriage; and Lynn, who after suffering from migraine for 50 years, shares how a clinical trial for a new treatment called CGRP targeted therapy is finally providing her with some relief.
To view the multimedia release go to:
https://www.multivu.com/players/English/7579759-robin-roberts-moving-beyond-migraine/
Truvia®, the #1 natural zero calorie sweetener, announced the launch of a multimillion dollar integrated marketing campaign, “From Nature. For Sweetness.” The new creative campaign, kicked off on September 24th, will further drive consumer awareness, trial and adoption of Truvia® products in the U.S. Since opening the U.S. market for stevia-based sweeteners in 2008, the Truvia® brand has led the natural sweetener category and now holds a 61 percent market share.
To view Multimedia News Release, go to http://www.multivu.com/mnr/58203-truvia-from-nature-for-sweetness-campaign-spotlights-stevia-sweetener
A small town lawyer is forced to fight a giant pharmaceutical company and the FDA to try to save his daughter’s life in Thompson’s edgy legal thriller. When his lawsuit uncovers fraud and corruption, he is confronted with an enemy who will resort to bribery, kidnapping and murder to win. Learn about the book and this author, www.larrydthompson.com Mystery Thriller
Off the coast of Central America, the Sea Diva, a tuna boat, sinks. Members of the crew are missing and what happened remains a mystery. As the case goes to trial, a missing crew member is believed to be at fault, but new evidence comes to light and the finger of guilt points in a completely unanticipated direction. Learn more here: http://bit.ly/1LHfMJ0
Vampires, werewolves, shapeshifters. All the dark creatures that humans want to believe are only myth.They live in the night. And when blood is spilled, justice must be served. Learn more about this book here: http://bit.ly/cT1dti and its author here: www.TheShadowKeepers.com Paranormal Romance
Audi stellt ab dem 16. Mai am Wörthersee in Kärnten ein außerordentlich emotionales Sportgerät vor. Das Audi e-bike Wörthersee vereint Elektroantrieb und Muskelkraft. Design-Chef Wolfgang Egger: „Als High-Performance E-Bike für Sport und Tricks bündelt es die Audi-Kernkompetenzen design, ultra, e-tron und connect.“ Bei der diesjährigen Wörthersee-Tour, dem 31. Treffen der Audi-, VW-, Seat- und Skoda-Fans, hat das E-Bike seine Weltpremiere: Trial-Biker Julien Dupont und Downhill-Spezialistin Petra Bernhard demonstrieren ihre Stunt- und Streetbike-Fähigkeiten.
http://multivu.prnewswire.com/mnr/prne/audi/53820/
In this short video Martin Rogers Head of Litigation and Dispute Resolution in Asia for Clifford Chance, and General Editor of The Hong Kong White Book discusses the changes to evidence and trial procedure following the implementation of Civil Justice Reform in Hong Kong (2 April 2009).http://cjrblog.sweetandmaxwell.com.hk
The Studio365 mobile app by Live365 mobile app enables broadcasters to manage their radio stations anywhere they go. With the Studio365 mobile app you can: • Create, preview, and manage your Shout Out Messages • Set and update your pre-rolls and station ID messages • Update your profile including title, image, description, etc. • Check your listener stats in real time • Listen and share your station anywhere New features coming soon To
use the Studio365 app, a Live365 broadcasting account is required. To
learn more about broadcasting with Live365, and to get a free 7 day
personal broadcasting trial using the Live365 platform, visit
http://www.live365.com/dj
iKITMovie is a free trial animation software for creating Stop Motion Animation, 3D Animation, Claymation, Brickfilms, Computer Animations for your personal and professional needs.
A recently published scientific study from Lund University by lead researcher Charlotte Erlanson-Albertsson, MD, PhD found that subjects who were trying to lose weight and used the patented spinach extract Appethyl on a daily basis lost 43 percent more weight compared to those ingesting a placebo.
In this clinical trial, overweight women were given either a daily five gram dose of Appethyl or a control drink immediately before breakfast. Researchers found that the weight of the women ingesting Appethyl decreased significantly at 43 percent more than subjects ingesting the control drink.
This is one of three studies that also compared the effects of Appethyl after 90 days with those found after the first dose and found no decline of effects, indicating that Appethyl takes effect after the first dose and is just as effective after long-term use. One study showed that Appethyl reduced hunger by 25 percent four hours after consumption, in addition to reducing thoughts about food by 33 percent.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7426951-appethyl-spinach-extract/
